Save lives
by becoming a
Venture Philanthropist
against cancer
100% of your donations go straight to the cause

The Foundation Fournier-Majoie's mission
As Venture Philanthropists, we combine sustained giving with the best business practices to save cancer patients.
The Foundation provides researchers-finders with resources and skills to help them to bring their oncological research projects to a successful conclusion.
Entrepreneurs against cancer

What we do
By supporting researchers-finders in their quest to become high-achieving entrepreneurs, we select promising oncological research projects and boost their odds of success so that innovation delivers tangible benefits for patients and the medical community.

Who we are
The Foundation, a registered charity set up by Dr Bernard Majoie in 2007, actively supports research efforts through the application of the principles of Venture Philanthropy, which combine a rigorous and professional approach with a generous spirit. A multidisciplinary team and a multidisciplinary network of experts assist project leaders.

How you can help us
You can make a REAL difference by becoming a Venture Philanthropist too. Bring hope and save cancer patients by making a donation, getting involved as a corporate partner or participating in our events.

The 100% model
Our pledge: 100% of your donations go straight to the projects. We want to make your generosity count. This is why every single cent or penny you donate will go to scientific projects that have been carefully selected by the Foundation and validated by our scientific experts. The Founder covers all operating expenses and communication costs for the Foundation, so you know exactly what your generosity has made possible.
News
Laureates
DNAlytics wins the Digital Wallonia 4 Good Startup Award
Our 2017 laureate, a spinoff from UCLouvain, has been rewarded for its reactivity and solutions provided to the FPS Health in the context of the Covid-19 pandemic (FR)
Read the articleScience
Colorectal cancer screening: “Don’t postpone your examination”
Colorectal cancer is the second leading cause of cancer death in Belgium. It is urgent for the over-50s to be screened, despite the Covid-19 pandemic (FR)
Read the articleLaureates
Plants to produce a new anti-cancer molecule
ATB Therapeutics (our 2017 laureat) has developed a platform capable of generating innovative molecules from plants to fight cancer. A promising fundraising (FR)
Read the article